| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England Journal of Medicine 361 (12), 1139-1151, 2009 | 10166 | 2009 |
| Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term … JW Eikelboom, L Wallentin, SJ Connolly, M Ezekowitz, JS Healey, ... Circulation 123 (21), 2363-2372, 2011 | 1161 | 2011 |
| Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ... Ep Europace 17 (10), 1467-1507, 2015 | 1155 | 2015 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1078 | 2010 |
| European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, W Hacke, J Oldgren, ... Europace 15 (5), 625-651, 2013 | 1008 | 2013 |
| RE-LY Steering Committee and Investigators: Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly N Engl J Med 360, 2066-2078, 2009 | 776* | 2009 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 684 | 2017 |
| Dronedarone in high-risk permanent atrial fibrillation SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ... New England Journal of Medicine 365 (24), 2268-2276, 2011 | 636 | 2011 |
| “Brugada” syndrome: clinical data and suggested pathophysiological mechanism M Alings, A Wilde Circulation 99 (5), 666-673, 1999 | 585 | 1999 |
| EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary H Heidbuchel, P Verhamme, M Alings, M Antz, W Hacke, J Oldgren, ... European heart journal 34 (27), 2094-2106, 2013 | 434 | 2013 |
| The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study SJ Connolly, L Wallentin, MD Ezekowitz, J Eikelboom, J Oldgren, ... Circulation 128 (3), 237-243, 2013 | 290 | 2013 |
| CLINICAL PERSPECTIVE LRC Dekker, CR Bezzina, JPS Henriques, MW Tanck, KT Koch, ... Circulation 114 (11), 1140-1145, 2006 | 281 | 2006 |
| Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ... The Lancet Neurology 11 (6), 503-511, 2012 | 270 | 2012 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 241 | 2018 |
| Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial J Oldgren, M Alings, H Darius, HC Diener, J Eikelboom, MD Ezekowitz, ... Annals of internal medicine 155 (10), 660-667, 2011 | 238 | 2011 |
| Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES T Vanassche, MN Lauw, JW Eikelboom, JS Healey, RG Hart, M Alings, ... European heart journal 36 (5), 281-288, 2014 | 236 | 2014 |
| Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome M Alings, L Dekker, A Sadee, A Wilde Pacing and Clinical Electrophysiology 24 (9), 1420-1422, 2001 | 186 | 2001 |
| Congenital Long-QT Syndrome Caused by a Novel Mutation in a Conserved Acidic Domain of the Cardiac Na+ Channel J Wei, DW Wang, M Alings, F Fish, M Wathen, DM Roden, AL George Jr Circulation 99 (24), 3165-3171, 1999 | 169 | 1999 |
| Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation L Wallentin, RD Lopes, M Hanna, L Thomas, A Hellkamp, S Nepal, ... Circulation 127 (22), 2166-2176, 2013 | 166 | 2013 |
| Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial JH Alexander, RD Lopes, L Thomas, M Alings, D Atar, P Aylward, S Goto, ... European heart journal 35 (4), 224-232, 2013 | 149 | 2013 |
